期刊文献+

生存素、Livin和zeste同源物-2在膀胱癌组织中的表达 被引量:9

Expression of survivin, livin and enhancer of zeste homolog-2 in bladder cancer tissue
原文传递
导出
摘要 目的 探讨膀胱癌组织中凋亡抑制基因生存素(Survivin)、Livin和zeste同源物-2(EZH-2)基因的表达及其相关性.方法 随机选取经病理检查明确诊断为膀胱癌的患者83例作为观察组,另选膀胱良性病变患者50例作为对照组,取观察组患者的膀胱癌组织和对照组患者正常的膀胱黏膜作为检测标本,利用免疫组织化学方法对标本中凋亡抑制蛋白Survivin、Livin和EZH-2蛋白染色,观察凋亡抑制基因Survivin、Livin和EZH-2基因的表达,并分析与临床资料的关系.对所有观察组患者进行为期5年的门诊随访.结果 膀胱癌组织中,Survivin、Livin和EZH-2的阳性表达率分别为74.70%、69.88%和83.13%,3种蛋白的阳性表达率均显著高于正常膀胱组织(P<0.05);Survivin和Livin的阳性表达与性别、TNM分期、病理分级和肿瘤数目无明显相关(P>0.05),而与组织来源和肿瘤复发明显相关(P<0.05);EZH-2的阳性表达与性别、肿瘤数目无明显相关(P>0.05),而与组织来源、TNM分期、病理分级和肿瘤复发明显相关(P<0.05);Survivin和Livin的表达呈正相关(r=0.744,P<0.01),Survivin和EZH-2的表达呈正相关(r=0.717,P<0.05),Livin和EZH-2的表达呈正相关(r=0.683,P<0.05).结论 Survivin、Livin和EZH-2在膀胱癌组织中的表达显著高于正常膀胱组织,且与肿瘤的发生发展有关,其阳性率的检测有助于判断其预后. Objective To investigate the expression of survivin,livin and enhancer of zeste homolog-2 (EZH-2) in bladder cancer tissues and their correlation with bladder cancer.Methods Eighty-three patients pathological diagnosed as bladder cancer were randomly selected as the observation group.Fifty patients with bladder benign lesions served as the control group.The bladder cancer tissues from observation group and the normal bladder mucosa sanples from control group were obtained detection of survivin,livin and EZH-2.The relationship between the expression of survivin,livin and EZH-2 with the clinical data was analyzed.All patients were subjected to 5-year outpatient follow-up.Results In the bladder cancer tissues,the positive expression rate of survivin,livin and EZH-2 was 74.70%,69.88% and 83.13% respectively,significantly higher than in normal bladder tissues correspondingly (P < 0.05).The positive expression of survivin and livin was not related with sex,TNM stage,pathological grading and the number of tumor (P > 0.05),but related to tissue origin and tumor recurrence (P < 0.05).The positive expression of EZH-2 had no correlation with the number of tumor and gender (P > 0.05),but related with tissue origin,TNM staging,pathological grading and recurrence of the tumor (P < 0.05).There was a positive correlation between survivin and livin (r =0.744,P < 0.01),or between survivin and EZH-2 (r =0.717,P < 0.05),or between livin and EZH-2 (r =0.683,P < 0.05).Conclusion The expression of survivin,livin and EZH-2 in bladder cancer tissues was significantly higher than that in normal bladder tissue,and related to the occurrence and development of tumor.The detection of the positive expression rate of survivin,livin and EZH-2 can evaluate the prognosis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第6期1230-1232,共3页 Chinese Journal of Experimental Surgery
基金 吉林省科技发展计划资助项目(201201045)
关键词 膀胱癌 生存素 LIVIN zeste同源物-2 Bladder cancer Survivin Livin Enhancer of zeste homolog-2
  • 相关文献

参考文献9

二级参考文献38

共引文献23

同被引文献68

  • 1宋希双,张志伟,车翔宇,姜涛,李先承,殷积斌.凋亡抑制基因Livin在膀胱癌中的表达及意义[J].中华泌尿外科杂志,2006,27(S1):37-39. 被引量:23
  • 2程亮,张绍渤,黄受方.低度恶性潜能之乳头状尿路上皮肿瘤[J].中华病理学杂志,2006,35(9):520-522. 被引量:5
  • 3HOU Jian-quan,HE Jun,WANG Xiao-lin,WEN Duan-gai,CHEN Zi-xing.Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer[J].Chinese Medical Journal,2006(20):1734-1739. 被引量:13
  • 4Mariappan P,Rai B,El-Mokadem I,et al.Real-life experience:early recurrence with hexvix photodynamic diagnosis-assisted transurethral resection of bladder tumour vs good-quality white light TURBT in new non-muscle-invasivebladder cancer[J].Urology,2015,86(2):327-331.
  • 5Kramer MW,RassweilerJJ,KleinJ,et al.En bloc resection of urothelium carcinoma of the bladder(EBRUC):a European multicenter study to compare safety,efficacy,and outcome of laser and electrical en bloc transurethral resection of bladder tumor[J].World J Urol,2015,33(12):1937-1943.
  • 6Elmamoun MH,Christmas TJ,Woodhouse CR.Destruction of the bladder by single dose Mitomycin C for low-stage transitional cell carcinoma(TCC)-avoidance,recognition,management and consent[J].BJU Int,2014,113(5b):E34-E38.
  • 7O'Brien T,Ray E,Chatterton K,et al.Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour(TURBT)plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer[J].BJU Int,2013,112(8):1096-1104.
  • 8Palou-Redorta J,Rouprêt M,Gallagher JR,et al.The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries[J].World J Urol,2014,32(2):525-530.
  • 9Mazaris E,Nafie S,Boustead G.Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer:factors resulting in pT0radical cystectomy specimens[J].Int Braz J Urol,2013,39(3):364-370.
  • 10Kobatake K,Mita K,Ohara S,et al.Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladdercancer[J].Oncol Lett,2015,10(2):1097-1102.

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部